Short Interest in Advanced Biomed Inc. (NASDAQ:ADVB) Drops By 72.3%

Advanced Biomed Inc. (NASDAQ:ADVB) was the target of a significant decrease in short interest in May. As of May 15th, there was short interest totaling 3,722 shares, a decrease of 72.3% from the April 30th total of 13,424 shares. Based on an average trading volume of 522,925 shares, the short-interest ratio is currently 0.0 days. Currently, 0.4% of the company’s stock are short sold.

Wall Street Analyst Weigh In

Separately, Weiss Ratings lowered Advanced Biomed from a “sell (d)” rating to a “sell (d-)” rating in a report on Tuesday. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has an average rating of “Sell”.

Advanced Biomed Trading Up 0.8%

Shares of NASDAQ ADVB opened at $3.91 on Friday. The stock’s 50 day simple moving average is $5.04. The firm has a market capitalization of $5.40 million, a P/E ratio of 0.81 and a beta of 0.56. Advanced Biomed has a twelve month low of $3.61 and a twelve month high of $24.00.

Advanced Biomed (NASDAQ:ADVB) last announced its quarterly earnings results on Friday, May 15th. The company reported ($0.38) earnings per share for the quarter.

Advanced Biomed Company Profile

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.